Accelerating the evaluation of and access to new lifesaving pneumococcal vaccines for the world's children
Please select a site to view PneumoADIP activities.
The PneumoADIP is organized around three main areas of activities.
Establishing the value of vaccination by demonstrating the burden of meningitis and pneumonia caused by pneumococcal bacteria and demonstrate the value of preventing it through vaccination.
Communicating effectively to key decision makers the knowledge about disease burden and the value of vaccination by assuring that research data are communicated through appropriate and effective communication channels.
Delivering the value of the vaccine by assuring that there is a predictable supply of quality vaccine at an affordable price, an adequate system to deliver it to the children who need it, and the financing to sustain its use.